Reply

Affiliations

¹ Department of Medicine (Division of Gastroenterology), Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
² Division of Gastroenterology, University of California San Diego, La Jolla, California.
³ Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.

Comment

Emily C L Wong et al. Clin Gastroenterol Hepatol. 2022 May.

. 2022 May;20(5):e1216-e1217.

doi: 10.1016/j.cgh.2021.05.051. Epub 2021 May 28.

¹ Department of Medicine (Division of Gastroenterology), Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
² Division of Gastroenterology, University of California San Diego, La Jolla, California.
³ Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.

No abstract available

Comment on

Infliximab vs Ustekinumab in Biologic Naive Crohn's Disease.
Huang X, Li X. Huang X, et al. Clin Gastroenterol Hepatol. 2022 May;20(5):e1216. doi: 10.1016/j.cgh.2021.05.013. Epub 2021 May 13. Clin Gastroenterol Hepatol. 2022. PMID: 33991689 No abstract available.